drugset / Trial / NCT00979693
Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is to find out about whether two sessions of psilocybin-assisted psychotherapy are safe and will help people who are anxious as a result of having stage IV melanoma and will involve two sessions of psychotherapy combined with either 4 or 25 mg psilocybin. The study will measure anxiety, depression, quality of life and spirituality before and after psilocybin-assisted psychotherapy, natural killer cells (a type of immune cell) will be counted from blood samples taken the day after psilocybin-assisted psychotherapy, and people will keep daily diaries reporting on how anxious they feel for each day in the study.
Timeline
- Start
- 2012-01
- Primary completion
- 2013-04
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Psilocybin | Other / unclassified | 4 mg | Oral |
| Comparator | Psilocybin | Other / unclassified | 25 mg | Oral |